Evidence map›Paper›PMID 31107298›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2019

New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men Who Have Sex With Men.

Erik Billings, Gustavo H Kijak, Eric Sanders-Buell, Nicaise Ndembi, Anne Marie OʼSullivan, Sylvia Adebajo, Afoke Kokogho, Mark Milazzo, Kara Lombardi, Stefan Baral and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 7 institutions in 2 countries.

Erik BillingsU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Gustavo H KijakU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Eric Sanders-BuellU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Nicaise NdembiInstitute of Human Virology-Nigeria, Abuja, Nigeria.
Anne Marie OʼSullivanU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Sylvia AdebajoPopulation Council Nigeria, Abuja, Nigeria.
Afoke KokoghoU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Mark MilazzoU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Kara LombardiU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Stefan BaralJohns Hopkins University, Baltimore, MD.
Rebecca NowakInstitute of Human Virology, University of Maryland, Baltimore, MD.
Habib RamadhaniInstitute of Human Virology, University of Maryland, Baltimore, MD.
Robert GramzinskiU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Merlin L RobbU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Nelson L MichaelU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Manhattan E CharuratInstitute of Human Virology, University of Maryland, Baltimore, MD.
Julie AkeU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Trevor A CrowellU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
Sodsai TovanabutraU.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD.
MHRP Viral Sequencing Core and the TRUST/RV368 Study Group
Walter Reed Army Institute of Research · USHenry M. Jackson Foundation · USUniversity of Maryland, Baltimore · USChildren's National · USInstitute of Human Virology · NGJohns Hopkins University · USMedical Laboratory Science Council of Nigeria · NG

Funding

Validation of Stigma Metrics for Marginalized Men R01MH110358 · NIMH · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2017 to 2021
$3.6M
Building TRUSTR01AI120913 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CHARURAT, MANHATTAN E · 2015 to 2019
$3.3M
TRUSTR01MH099001 · NIMH · UNIVERSITY OF MARYLAND BALTIMORE · PI CHARURAT, MANHATTAN E · 2012 to 2014
$2.9M
Epidemiology Research Training for Public Health Impact in Nigeria (Epi-Nigeria)D43TW010051 · FIC · UNIVERSITY OF MARYLAND BALTIMORE · PI ABIMIKU, ALASH'LE G., CHARURAT, MANHATTAN E · 2016 to 2020
$1.5M
Role of anal microbiota, local cytokines and HIV in persistence of high-risk human papillomavirusK07CA225403 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI NOWAK, REBECCA G. · 2018 to 2022
$677k
FIC NIH HHS D43 TW010051NIAID NIH HHS R01 AI120913NIMH NIH HHS R01 MH099001NIMH NIH HHS R01 MH110358PEPFAR
6 · The paper itself

Abstract

backgroundHIV-1 circulating recombinant forms (CRF) containing subtype B are uncommon in sub-Saharan Africa. Prevalent infections observed during enrollment of a prospective study of men who have sex with men (MSM) from Lagos, Nigeria, revealed the presence of a family of subtype B and CRF02_AG recombinants. This report describes the HIV-1 genetic diversity within a high-risk, high-prevalence, and previously undersampled cohort of Nigerian MSM.

methodsBetween 2013 and 2016, 672 MSM were enrolled at the Lagos site of the TRUST/RV368 study. Prevalent HIV-1 infections were initially characterized by pol sequencing and phylogenetic subtyping analysis. Samples demonstrating the presence of subtype B were further characterized by near full-length sequencing, phylogenetic, and Bayesian analyses.

resultsWithin this cohort, HIV-1 prevalence was 59%. The major subtype was CRF02_AG (57%), followed by CRF02/B recombinants (15%), subtype G (13%), and smaller amounts of A1, B, and other recombinants. Nine clusters of closely related pol sequences indicate ongoing transmission events within this cohort. Among the CRF02_AG/B, a new CRF was identified and termed CRF95_02B. Shared risk factors and Bayesian phylogenetic inference of the new CRF95_02B and the similarly structured CRF56_cpx indicate a Nigerian or West African origin of CRF56_cpx before its observation in France.

conclusionWith high HIV-1 prevalence, new strains, and multiple transmission networks, this cohort of Nigerian MSM represents a previously hidden reservoir of HIV-1 strains, including the newly identified CRF95_02B and closely related CRF56_cpx. These strains will need to be considered during vaccine selection and development to optimize the design of a globally effective HIV-1 vaccine.

Indexed as

Homosexuality, MalePhylogenyRecombination, GeneticSexual and Gender MinoritiesAdultBayes TheoremFranceGenome, ViralHIV-1HIV InfectionsHumansMaleMolecular EpidemiologyNigeriaPrevalenceProspective Studies

Identifiers

PMID31107298
PMCPMC6625905
OpenAlexW2945275268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.